Detalhe da pesquisa
1.
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
Clin Infect Dis
; 78(2): 259-268, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37740559
2.
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials.
Clin Infect Dis
; 76(3): e1157-e1165, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031403
3.
Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical Need.
Clin Infect Dis
; 77(3): 380-387, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021650
4.
FDA Public Workshop Summary-Addressing Challenges in Inhaled Antifungal Drug Development.
Clin Infect Dis
; 2023 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37802928
5.
FDA Public Workshop Summary-Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs.
Clin Infect Dis
; 74(11): 2061-2066, 2022 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34651656
6.
Antibiotics needed to treat multidrug-resistant infections in neonates.
Bull World Health Organ
; 100(12): 797-807, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36466207
7.
Concordance of Early and Late End Points for Community-acquired Bacterial Pneumonia Trials.
Clin Infect Dis
; 73(9): e2607-e2612, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32584969
8.
Trends in Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia Trials.
Clin Infect Dis
; 73(3): e602-e608, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33173946
9.
US Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®).
Clin Infect Dis
; 72(12): e1103-e1111, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33393598
10.
Needed: Antimicrobial Development.
N Engl J Med
; 380(8): 783-785, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30786194
11.
Hypersensitivity reactions associated with fidaxomicin use.
Clin Infect Dis
; 58(4): 537-9, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24178248
12.
Hypoglycemia in patients treated with linezolid.
Clin Infect Dis
; 59(8): e93-5, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24965346
13.
Use of an active surveillance system by the FDA to observe patterns of quinine sulfate use and adverse hematologic outcomes in CMS Medicare data.
Pharmacoepidemiol Drug Saf
; 23(9): 911-7, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24872151
14.
Cefiderocol Dosing for Patients Receiving Continuous Renal Replacement Therapy.
Clin Pharmacol Ther
; 112(5): 1004-1007, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35792715
15.
Cardiovascular risks with azithromycin.
N Engl J Med
; 369(6): 581, 2013 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23930274
16.
Cardiovascular risks with azithromycin and other antibacterial drugs.
N Engl J Med
; 368(18): 1665-8, 2013 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23635046
17.
Meta-analysis of a possible signal of increased mortality associated with cefepime use.
Clin Infect Dis
; 51(4): 381-9, 2010 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20624065
18.
Achieving Regulatory Alignment for Anti-Infective Clinical Trials.
ACS Infect Dis
; 6(6): 1308-1310, 2020 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32529834
19.
Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach.
J Pediatric Infect Dis Soc
; 8(1): 60-62, 2019 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438520
20.
Parents' perceived obstacles to pediatric clinical trial participation: Findings from the clinical trials transformation initiative.
Contemp Clin Trials Commun
; 9: 33-39, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29696222